Mr. Deepak Lokwani
M. Pharm, Ph.D. | Associate Professor | Department : Pharmaceutical Chemistry
+91–9372593591
dklokwani@gmail.com
Teaching: 15 (Including Research and Teaching)
National: 03
International: 69
National: 06
International: 03
Received ICMR Senior Research Fellowship (SRF) in year 2013-2014
Computer Aided Drug Design, Synthesis of Bioactive compounds.
- Book Chapter: Exploring the Range of Knowledge-Based Prediction Applications in Chemistry. In edited Book: Artificial Intelligence for Chemical Sciences Concepts, Models, and Applications. Apple Academic Press; 2025, pp 321-335
- Book Chapter:Recent updates in chemistry of Alzheimer’s: Synthetic molecules. In edited Book:. Alzheimer’s Disease and Advanced Drug Delivery Strategies. Academic Press (Elsevier), 2024; pp 33-46.
- Book: Sivakumar Redasani, Dr. Anant Deshpande, Dr. Deepak Lokwani, Sandeep Walsangikar, Dr. Sachin Rohane. Drug Design and Discovery: Nirali Prakashan, India, 2023
- Book Chapter: Potential Technologies to Develop Cellulose Beads and Microspheres. In edited Book: Regenerated Cellulose and Composites. Springer; pp 145-176
- Book: Dr. Akhil Nagar, Deepak Lokwani, Dr. Atul Bendale, Mr. Pritam B. Chaudhari. Practical Manual of Inorganic, Organic & Medicinal Chemistry. IP Innovative Publication Pvt. Ltd, India, 2023
- Book: Dr. Amit G.Nerkar., Deepak Lokwani and Mr. Rushikesh Ukirde. Textbook of Biochemistry. S. Vikas and Company (Medical Publishers – PvBooks), India, 2021
- Book: Deepak K. Lokwani, Amit G. Nerkar. Concise course in Pharmaceutical Organic Chemistry-II, Vikas and Company (Medical Publishers – PvBooks), India, 2020
- Book: Deepak K. Lokwani, Amit G. Nerkar. Concise course in Pharmaceutical Organic Chemistry-I, Vikas and Company (Medical Publishers – PvBooks), India, 2019
- Book: Amit G. Nerkar, Deepak K. Lokwani, Jyoti Tangde, Concise course in Pharmaceutical Organic Chemistry-III. Vikas and Company (Medical Publishers – PvBooks), India, 2018
- District Coordinator for Aavishkar 2024-25 Research Convention – Sant Gadge Baba Amravati University, Amravati, Maharashtra, India
- Guest Editor – Special Issue “Computational and Synthetic Approaches of Drug Discovery in Cancer and Neurological Disorders” – Journal “Molecules”, Publisher – MDPI
- Worked as UGC Project fellow and ICMR SRF at Department of Chemical Technology, Dr. Babasaheb Ambedkar Marathwada University, Aurangabad, Maharashtra from Feb 2010 to Dec 2014.
- Peer-Reviewer (Reviewed more than 50 manuscripts) for Journals published in Elsevier, Springer Nature, American Chemical Society, Taylor & Francis, Wiley, and MDPI.
- Ligand-Enzyme docked image selected as cover page for Journal of Heterocyclic Chemistry (Wiley Interscience) (DOI: 10.1002/jhet.3013). in Year 2017
- Received National Prize for Short Film made for CSIR-OSDD-VP short Video Competition on Topic “The Need of New Drugs for Tuberculosis” in year 2014
- Received Outstanding Publication Award by vLife Sciences, Pune in the field of Computer Aided Drug and Molecular Design in year 2011.
- Qualified GATE 2007 conducted by IIT, Kanpur with 94.08 Percentile (AIR 1079, GATE Score 413).
Sr. No. | Title of Research Paper | Name of Authors | Name of Journal | Year, Volume, Page No. | IF |
1. | Naphthalene-4H-Chromene Molecular Hybrids as Dual Cholinesterase Inhibitors for the Treatment of Alzheimer’s Disease | Vinod Ugale, Nissi Sharon, Chandradip Salunkhe, Jotiram Salunkhe, Deepak Lokwani, Kalpesh Patil, Pedavenkatagari Narayana Reddy, Prasad Kulkarni | Drug Development Research | 2026, 87, e70338 | 4.2 |
2. | Empagliflozin mitigates depression-like behavior in diabetic mice via putative CRF1 receptor modulation: behavioral, biochemical and in silico studies | Sachin P. Borikar, Mamata S. Chavan, Shirish P. Jain, Deepak K. Lokwani, Deepali N. Tapre | Naunyn-Schmiedeberg’s Archives of Pharmacology | Available Online (2026) | 4.0 |
3. | 7‑Hydroxyflavone mitigates partial sciatic nerve ligation–induced neuropathic pain via modulation of oxidative and inflammatory pathways | Ashish D. Tale, Shirish P. Jain, Siddharth V. Kamble, Sachin P. Borikar, Shailesh M. Kewatkar, Deepak K. Lokwani, Satish P. Shelke, Dipak V. Bhusari, Sangameshwar B. Kanthale | Naunyn-Schmiedeberg’s Archives of Pharmacology | Available Online (2026) | 4.0 |
4. | Natural compounds as PPAR-γ modulators in inflammatory bowel disease: Insights from molecular docking and dynamics simulations | Bhoomendra A. Bhongadea, Areeg Anwer Ali, Nikhil D. Amnerkar, Saurabh C. Khadse, Deepak K. Lokwani, Rajesh B. Patil, Mahreen Arooj, Balaji Venkataraman, Mauro Pessia, Shreesh Ojha, Mohamed El-Tanani, Sandeep B. Subramanya | Letters in Drug Design & Discovery | 2025, 22, 100345 | 1.6 |
5. | Microwave-assisted synthesis, spectral, biological and computational analysis of pyridine bis-hydrazone metal complexes | B. Krishna Kumari, D. Kanagavel, K. Arun Prasath Lingam, Vinod Ugale, Deepak Lokwani | Journal of Molecular Structure
| 2026, 1362, 145762 | 4.9 |
6. | Structural Exploration of Pyrazine-1,2,3-Triazole Hybrids as Selective Acetylcholinesterase Inhibitors for the Treatment of Alzheimer’s Disease | Madala Ramesh, Pannala Padmaja, Vinod Ugale, Atul Shirkhedkar, Rahul Pawara, Deepak Lokwani, Srinivas Manda, Pedavenkatagari Narayana Reddy
| Drug Development Research
| 2026, 87, e70249 | 4.2 |
7. | Therapeutic potential of 7‑hydroxyflavone in letrozole‑induced polycystic ovarian syndrome via regulation of oxidative stress, inflammation, hormonal and biochemical dysregulation | Ashish Tale, Deepak Lokwani, Komal Mandade, Sachin Borikar, SangameshwarKanthale, Satish Shelke, Shirish Jain | Naunyn-Schmiedeberg’s Archives of Pharmacology | Available Online (2026) | 4.0 |
8. | Development of Novel Paullone Derivatives as Selective Acetylcholinesterase Inhibitors for the Treatment of Alzheimer’s disease | Srinivas Manda, Pedavenkatagari Narayana Reddy, Pannala Padmaja, Vinod G Ugale, Deepak Lokwani, Amod Patil, Srinivas Pasikanti
| Journal of Molecular Structure
| 2025, 1343, 142862 | 4.7 |
9. | Computational Investigation of Natural Substances as SARS-CoV-2 Main Protease Inhibitors: A Virtual Screening Method | Deepak K Lokwani, Sangita R Chavan, Shirish P Jain, Samiksha R Shengokar, Titiksh L Devale | Recent Advances in Anti-Infective Drug Discovery | 2025 (Available Online) | 0.3 |
10. | Development of novel 9H‑carbazole‑4H‑chromene hybrids as dual cholinesterase inhibitors for the treatment of Alzheimer’s disease | Nissi Sharon, Vinod G. Ugale, Pannala Padmaja, Deepak Lokwani, Chandradeep Salunkhe, Padmaja Shete, Pedavenkatagari Narayana Reddy, Prasad P. Kulkarni | Molecular Diversity | 2024 (Available Online) | 3.8 |
11. | Design, synthesis, and biological evaluation of novel 2,3-Di-O-Aryl/Alkyl sulfonate derivatives of L-ascorbic acid: Efficient access to novel anticancer agents via in vitro screening, tubulin polymerization inhibition, molecular docking study and ADME predictions | Santosh R. Deshmukh, Archana S. Nalkar, Aniket P. Sarkate, Shailee V. Tiwari, Deepak K. Lokwani, Shankar R. Thopate | Bioorganic Chemistry | 147 (2024) 107402 | 5.1 |
12. | Exploring the therapeutic potential of SGLT2 inhibitors in cancer treatment: integrating in silico and in vitro investigations | Prasanna Mohite, Deepak K. Lokwani, Nikhil S. Sakle1 | Naunyn-Schmiedeberg’s Archives of Pharmacology | 2024 (Available Online) | 3.6 |
13. | Targeting Allosteric Site of PCSK9 Enzyme for the Identification of Small Molecule Inhibitors: An In Silico Drug Repurposing Study | Nitin Bharat Charbe, Flavia C. Zacconi, Venkata Krishna Kowthavarapu, Churni Gupta, Sushesh Srivatsa Palakurthi, Rajendran Satheeshkumar, Deepak K. Lokwani, Murtaza M. Tambuwala, and Srinath Palakurthi
| Biomedicines | 2024, 12, 286 | 4.7 |
14. | Exploration of 2-(Substituted Phenyl)-thiazolidin-4-one as Anticancer Agents | Rahul B. Shinde, Dattatraya N. Pansare, Aniket P. Sarkate, Shailee V. Tiwari, Rohini N. Shelke, Deepak Lokwani, Shirish Jain, and Ashok M. Zine | Russian Journal of Bioorganic Chemistry, 2023, | Vol. 49, Suppl. 1, pp. S81–S95 |
|
15. | Virtual Screening of Natural Compounds as Potential SARS-CoV-2 Main Protease Inhibitors: A Molecular Docking | Deepak K. Lokwani ,Sangita R. Chavan, Aniket P. Sarkate, Prabhu M. Natarajan, Vidhya R. Umapathy and Shirish P. Jain | Chem. Proc. | 2023, 14, 85. | 0.00 |
16. | In-silico studies of 2-aminothiazole derivatives as anticancer agents by QSAR, molecular docking, MD simulation and MM-GBSA approaches | Trupti S. Chitre, Purvaj V. Hirode, Deepak K. Lokwani, Aniket L. Bhatambrekar, Sayli G. Hajare, Shubhangi B. Thorat, D. Priya, Kunal B. Pradhan, Kalyani D. Asgaonkar and Shirish P. Jain | Journal Of Biomolecular Structure And Dynamics(Available online) | 2023 (Available Online) | 4.40 |
17. | Novel alkyl-substituted 4-methoxy benzaldehyde thiosemicarbazones: Multi-target directed ligands for the treatment of Alzheimer’s disease | Mokshada Varma, Vinod Ugale, Javeria Shaukat, Michael Hollmann, Padmaja Shete, Bhupendra Shravage, Sakharam Tayade, Avinash Kumbhar, Ray Butcher, Vinod Jani, Uddhavesh Sonavane, Rajendra Joshi, Deepak Lokwani, Prasad Kulkarni | Eur. J. Pharmacol | 2023 (Available Online) | 5.00 |
18. | GluN2B subunit selective N‑methyl‑D‑aspartate receptor ligands: Democratizing recent progress to assist the development of novel | Vinod Ugale, Rutuja Deshmukh, Deepak Lokwani, P. Narayana Reddy, Saurabh Khadse, Prashant Chaudhari, Prasad P. Kulkarni | Mol. Div. | 2023 (Available Online) | 3.80 |
19. | Molecular hybridization-based design, PASE three-component synthesis, antiproliferative activity and molecular modelling studies of N,N-dimethylaminophenyl substituted-5H-chromeno[2,3-b]pyridine analogs | Pedavenkatagari Narayana Reddy, Nissi Sharon, Pannala Padmaja, Vinod G. Ugale, Deepak Lokwani, Shirish jain, Pragati P, Anjali K | J. Mol. Struct. | 2023, 1286, 135589 | 3.80 |
20. | Identification of structural scaffold from interbioscreen (IBS) database to inhibit 3CLpro, PLpro, and RdRp of SARS-CoV-2 using molecular docking and dynamic simulation studies | Vikas R. Patil , Ashish M. Dhote , Rina Patil, Nikhil D. Amnerkar ,Deepak K. Lokwani, Vinod G. Ugale , Nitin B. Charbe , Sandip D. Firke , Prashant Chaudhari , Sapan K. Shah, Chetan H. Mehta , Usha Y. Nayak and Saurabh C. Khadse | J. Biomol. Struct. Dyn. | 2023 (Available Online) | 4.40 |
21. | In silico approach towards polyphenols as targeting glucosamine-6-phosphate synthase for Candida albicans | Sachin Dhawale, Madhuri Pandit, Kanchan Thete, Dnyaneshwari Ighe, Sachin Gawale, Pallavi Bhosle, Deepak K. Lokwani | J. Biomol. Struct. Dyn. | 2023 (Available Online) | 4.40 |
22. | Molecular Docking Studies and Application of 6-(1-Arylmethanamino)-2-Phenyl-4H-Chromen-4-Ones as Potent Antibacterial Agents | Nitin M. Thorat, Vinnayak S. Khodade, Ajit P. Ingale, Deepak K. Lokwani, Aniket P. Sarkate& Shankar R. Thopate | PolycyclAromatCompd | 2023 (Available Online) | 2.40 |
23. | Design, synthesis, and biological evaluation of novel quinoline derivatives as small molecule mutant EGFR inhibitors targeting resistance in NSCLC: In vitro screening and ADME predictions | Ramakant A. Kardile, Aniket P. Sarkate, Deepak K. Lokwani, Shailee V. Tiwari, Rajaram Azad, Shankar R. Thopate | Eur. J. Med. Chem. | 2023, 245, 114889 | 6.70 |
24. | Design, synthesis, and pharmacological evaluation of [1, 3] dioxolo‑chromeno[2,3‑b]pyridines as anti‑seizure agents | Visarapu Malathi, Nissi Sharon, Pannala Padmaja, Deepak Lokwani, Saurabh Khadse, Prashant Chaudhari, Atul A. Shirkhedkar, Pedavenkatagari Narayana Reddy, Vinod G. Ugale | Mol. Div. | 2023, 27, 1809-1827 | 3.80 |
25. | Molecular dynamic simulations based discovery and development of thiazolidin-4-one derivatives as EGFR inhibitors targeting resistance in nonsmall cell lung cancer (NSCLC) | Kshipra S. Karnik, Aniket P. Sarkate, Deepak K. Lokwani, Shailee V. Tiwari, | J. Biomol. Struct. Dyn. | 2023, 41:10, 4696-4710 | 4.40 |
26. | Explorations of novel pyridine-pyrimidine hybrid phosphonate derivatives as aurora kinase inhibitors | Shailee V. Tiwari, Aniket P. Sarkate, Deepak K. Lokwani, Dattatraya N. Pansare, | Bioorg. Med. Chem. Lett. | 2022, 67, 128747 | 2.70 |
27. | Strategic analyses to identify key structural features of antiviral/antimalarial compounds for their binding interactions with 3CLpro, PLpro and RdRp of SARS-CoV-2: in silico molecular docking and dynamic simulation studies | Ashish M. Dhote, Vikas R. Patil, Deepak K. Lokwani, Nikhil D. Amnerkar, Vinod G. Ugale, Nitin B. Charbe, Bhoomendra A. Bhongade and Saurabh C. Khadsea | J. Biomol. Struct. Dyn. | 2021 (Available Online) | 3.31 |
28. | Pyridine/Pyrimidine Substituted Imidazol-5-one Analogs as HIV-1 RT Inhibitors: Design, Synthesis, Docking and Molecular Dynamic Simulation | Santosh Mokale, Deepak Lokwani,* and Abdul Mujaheed | Curr HIV Res | 2021 (Available Online) | 1.58 |
29. | In silico screening of phytopolyphenolics for the identification of bioactive compounds as novel protease inhibitors effective against SARS-CoV-2 | Mithun Rudrapal, Abdul Rashid Issahaku, Clement Agoni, Atul R. Bendale, | J. Biomol. Struct. Dyn. | 2021 (Available Online) | 3.31 |
30. | One pot synthesis, in silico study and evaluation of some novel flavonoids as potent topoisomerase II inhibitors | Aniket P. Sarkate*, Vidya S. Dofe, Shailee V. Tiwari, Deepak K. Lokwani*, Kshipra S. Karnik, Darshana D. Kamble, Mujahed H.S.H. Ansari Suneel Dodamani, Sunil S. Jalalpure, Jaiprakash N. Sangshetti, Rajaram Azad, Prasad V.L.S. Burra, Shashikant V. Bhandari | Bioorg. Med. Chem. | 2021, 40,127916 | 2.823 |
31. | Design and synthesis of novel conformationally constrained 7,12-dihydrodibenzo[b,h][1,6] naphthyridine and 7H-Chromeno[3,2-c] quinoline derivatives as topoisomerase I inhibitors: In vitro screening, molecular docking and ADME predictions | Ramakant A. Kardile, Aniket P. Sarkate, Avinash S. Borude, Rajendra S. Mane, | Bioorg. Chem. | 2021, 115, 105174 | 5.275 |
32. | Structure-Based Site of Metabolism (SOM) Prediction of Ligand for CYP3A4 Enzyme: Comparison of Glide XP and Induced Fit Docking (IFD) | Deepak K. Lokwani, Aniket P. Sarkate, Kshipra S. Karnik, Anna Pratima G. Nikalje and Julio A. Seijas | Molecules | 2020, 25, 1622 | 4.411 |
33. | Ultrasound assisted synthesis of tetrazole based pyrazolines and isoxazolines as potent anticancer agents via inhibition of tubulin polymerization | Vidya S. Dofe, Aniket P. Sarkate, Shailee V. Tiwari, Deepak K. Lokwani, Kshipra S. Karnik, | Bioorg. Med. Chem. Lett. | 30 (2020) 127592 | 2.823 |
34. | Investigating the Impact of Different Acrylamide (Electrophilic Warhead) | Harun Patel, Iqrar Ahmad, Harsha Jadhav, Rahul Pawara, Deepak Lokwani and Sanjay Surana | Comb. Chem. High Throughput Screen | 2020 (Available Online) | 1.339 |
35. | Development of triple mutant T790M/C797S allosteric EGFR inhibitors: a computational approach | KS Karnik, AP Sarkate, DK Lokwani, IS Narula, PVLS Burra, PS Wakte | J. Biomol. Struct. Dyn. | 2020 (Available Online) | 3.31 |
36. | BREED based de novo hybridization approach: generating novel T790M/C797S-EGFR tyrosine kinase inhibitors to overcome the problem of mutation and resistance in non-small cell lung cancer (NSCLC) | HM Patel, M Shaikh, I Ahmad, D Lokwani, SJ Surana | J. Biomol. Struct. Dyn. | 2020 (Available Online) | 3.31 |
37. | N-Benzylation of 6-aminoflavone by reductive amination and efficient access to some novel anticancer agents via topoisomerase II inhibition | Nitin M. Thorat, Aniket P. Sarkate, Deepak K. Lokwani, Shailee V. Tiwari, Rajaram Azad & Shankar R. Thopate | Molecular Diversity | 2020 (Available Online) | 2.943 |
38. | Hetero-substituted sulfonamido-benzamide hybrids as glucokinase activators: Design, synthesis, molecular docking and in-silico ADME evaluation | Saurabh C. Khadse Nikhil D. Amnerkar, Krushna S. Dighole, Ashish M.Dhote, Vikas R.Patil, Deepak K. Lokwani, Vinod G.Ugale, Nitin B.Charbe, Vivekanand A. Chatpalliwar | J. Mol. Struct. | 2020, 1222, 128916 | 3.196 |
39. | Synthesis and evaluation of novel sulfonamide analogues of 6/7-aminoflavones as anticancer agents via topoisomerase II inhibition | Rohini N. Shelke, Dattatraya N. Pansare, Aniket P. Sarkate, Ishudeep K. Narula, Deepak K. Lokwani, Shailee V. Tiwari, Rajaram Azad, Shankar R. Thopate | Bioorg. Med. Chem. Lett. | 2020, 30, 127246 | 2.823 |
40. | Pharmaceutical analysis combined with in-silico therapeutic andtoxicological profiling on zileuton and its impurities to assist in modern drug discovery | Saurabh B. Ganorkara, Yvan Vander Heyden, Atul A. Shirkhedkar, Deepak K. Lokwani, Dinesh M. Dhumal, Preeti S. Bobade | J. Pharma. Biomed. Anal. | 2020, 179, 112982 | 3.935 |
41. | Quinazolin-4-one derivatives lacking toxicity-producing attributes as glucokinase activators: design, synthesis, molecular docking, and in-silico ADMET prediction. | Saurabh C. Khadse, Nikhil D. Amnerkar , Manasi U. Dave, Deepak K. Lokwani, Ravindra R. Patil, Vinod G. Ugale, Nitin B. Charbe and Vivekanand A. Chatpalliwar | Future J. Pharma. Sci. | 2019, 5, 11 | 0 |
42. | New amide linked dimeric 1, 2, 3-triazoles bearing aryloxy scaffolds as a potent antiproliferative agents and EGFR tyrosine kinase phosphorylation inhibitors. | TR Deshmukh, AP Sarkate, DK Lokwani, SV Tiwari, R Azad, BB Shingate, | Bioorg. Med. Chem. lett. | 2019, 19, 126618 | 2.823 |
43. | Caesalpinia pulcherrima arrests cell cycle and triggers reactive oxygen species-induced mitochondrial-mediated apoptosis and necroptosis via modulating estrogen and estrogen receptors. | NS Sakle, D Lokwani, SN Mokale | Pharmacognosy Magazine | 2019, 15 (64), 288 | 1.085 |
44. | A new efficient domino approach for the synthesis of coumarin-pyrazolines as antimicrobial agents targeting bacterial D-alanine-D-alanine ligase. | Asha V. Chate, Ankita A. Redlawar, Giribala M. Bondle, Aniket P. Sarkate, Shailee V. Tiwari and Deepak K. Lokwani, | New J. Chem. | 2019, 43, 9002-9011 | 3.591 |
45. | DIPEAc promoted one-pot synthesis of dihydropyrido [2, 3-d: 6, 5-d’] dipyrimidinetetraone and pyrimido [4, 5 d] pyrimidine derivatives as potent tyrosinase inhibitors and anticancer agents: in vitro screening, molecular docking and ADMET predictions. | M Bhosle, LD Khillare, JR Mali, A Sarkate, DK Lokwani, SV Tiwari, | New J. Chem. | 2018, 42, 18621 | 3.591 |
46. | Design, Synthesis and Anti-breast Cancer Activity of Some Novel Substituted Isoxazoles as Anti-breast Cancer Agent. | Santosh N Mokale, Nikhil S Sakle, Swati A Bhavale, Deepak K Lokwani, Vishakha Shelke. | Anti-Cancer Agents in Med. Chem. | 2018, 18 (7), 1009-1015 | 2.505 |
47. | Synthesis, Biological Evaluation and Computational Study of New Quinoline Hybrids as Antitubercular Agent | Z Zaheer, SI Shaikh, SN Mokale, DK Lokwani, | Lett. Drug Des. Discov. | 2018, 15 (9), 914-922 | 1.15 |
48. | Synthesis, Biological Evaluation, Molecular Docking Study and Acute Oral Toxicity Study of Coupled Imidazole-Pyrimidine Derivatives, | Shailee V. Tiwari, Anna P.G. Nikalje, Deepak K. Lokwani, Aniket P. Sarkate, Kizukala Jamir. | Lett. Drug Des. Discov. | 2018, 15(5), 475-487 | 1.15 |
49. | Microwave-Assisted Facile Synthesis, Anticancer Evaluation and Docking Study of N-((5-(Substituted methylene amino)-1,3,4-thiadiazol-2-yl)methyl) Benzamide Derivatives | Shailee V. Tiwari, Sumaiya Siddiqui, Julio A. Seijas , M. Pilar Vazquez-Tato, Aniket P. Sarkate, Deepak K. Lokwani and Anna Pratima G. Nikalje, | Molecules | 2017, 22(6), 995. | 4.411 |
50. | Novel 2-(nitrooxy)ethyl 2-(4-(substituted phenyl)-2-((substituted phenyl)amino)thiazol-5-yl)acetate as Anti-inflammatory, Analgesic and Nitric Oxide Releasing Agents: Synthesis and Molecular Docking Studies | Aniket P. Sarkate, Deepak K. Lokwani, Kshipra S. Karnik and Devanand B. Shinde | Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry | 2017, 16, 153-167 | 0 |
51. | Novel O‐Alkylated Chromones as Antimicrobial Agents: Ultrasound Mediated Synthesis, Molecular Docking and ADME Prediction, | VS Dofe, AP Sarkate, DK Lokwani, DB Shinde, SH Kathwate, CH Gill | J. Hetero. Chem. | 2017, 54 (5), 2678-2685 | 1.484 |
52. | Development of New Pyrazole Hybrids As Antitubercular Agents: Synthesis, Biological Evaluation And Molecular Docking Study | Sameer I. Shaikh, Zahid Zaheer, Santosh N. Mokale, Deepak K. Lokwani | Int. J. Pharm. Pharm. Sci. | Vol 9, Issue 11, 50-56 | 0 |
53. | Synthesis and Evaluation of 1,2,3-Triazole-Containing Vinyl and Allyl Sulfones as Anti-Trypanosomal Agents, | William Doherty, Nikoletta Adler, Andrew Knox, Derek Nolan, Joanna McGouran, Anna Pratima Nikalje, Deepak Lokwani, Aniket Sarkate, and Paul Evans, | Eur. J. Org. Chem. | 2017, 2017, 175–185. | 2.889 |
54. | Synthesis, antimicrobial evaluation, and molecular docking studies of novel chromone based 1,2,3-triazoles, | Vidya S. Dofe, Aniket P. Sarkate, Deepak K. Lokwani, Santosh H. Kathwate, Charansingh H. Gill | Res Chem Intermed | 2017, 43, 15-28 | 2.262 |
55. | Ultrasound mediated one-pot, three component synthesis, docking and ADME prediction of novel 5-amino-2-(4-chlorophenyl)-7-substituted phenyl-8,8a-dihydro-7h-(1,3,4)thiadiazolo(3,2-α)pyrimi-dine-6-carbonitrile derivatives as anticancer agents, | Shailee V. Tiwari, Julio A. Seijas, M. Pilar Vazquez-Tato, Aniket P. Sarkate, Deepak K. Lokwani and Anna Pratima G. Nikalje, | Molecules | 2016, 21(8), 894 | 3.267 |
56. | Design of selective TACE inhibitors using molecular docking studies: Synthesis and preliminary evaluation of anti-inflammatory and TACE inhibitory activity, | A.P. Sarkate, P.R. Murumkar, D.K. Lokwani, A.D. Kandhare, D.B. Shinde, K.G.Bothara, | SAR QSAR Environ Res. | 2015, 26, 905 | 2.053 |
57. | Synthesis and docking studies of 2-(nitrooxy) ethyl-4-(2-(substitutedphenyl)-4-(substitutedphenyl)-1h-imidazol-1-yl)benzoate as anti-inflammatory, analgesic and nitric oxide releasing agents, | Aniket P. Sarkate, Deepak K. Lokwani, Sushilkumar S. Bahekar, Devanand B. Shinde, | Int. J. Pharm. Pharmaceut. Sci. | 2015, 7, 197 | 0 |
58. | Structure Based Library Design (SBLD) for new 1,4-dihydropyrimidine scaffold as simultaneous COX-1/COX-2 and 5-LOX inhibitors, | Deepak Lokwani, Rajaram Azad, Aniket Sarkate, Pallu Reddanna, Devanand Shinde, | Bioorg. Med. Chem. | 2015, 23, 4533 | 3.073 |
59. | Green synthesis and biological evaluation of some new benzothiazolo [2,3-b] quinazolin-1-ones as anticancer agents, | Jaiprakash N. Sangshetti, Deepak K. Lokwani, Rashmi S. Chouthe, Bhuvan Raval, Firoz A. Kalam Khan, Devanand B. Shinde | Med. Chem. Res. | 2014, 23, 4893 | 1.783 |
60. | Synthesis, in-vitro reverse transcriptase inhibitory activity and docking study of some new imidazol-5-one analogs. | Santosh Mokale, Deepak Lokwani, Devanand Shinde | Med. Chem. Res. | 2014, 23, 3752 | 1.783 |
61. | 3D QSAR studies based in-silico screening of 4,5,6-triphenyl-1,2,3,4-tetrahydropyrimidine analogs for anti- inflammatory activity | Deepak Lokwani, Santosh Mokale, Devanand Shinde | Eur. J. Med. Chem. | 2014, 73, 233 | 5.572 |
62. | 3D-QSAR and docking studies of benzoyl urea derivatives as tubulin-binding agents for antiproliferative activity | Deepak K. Lokwani, Aniket P. Sarkate, Devanand B. Shinde | Med. Chem. Res. | 2013, 22, 1415 | 1.783 |
63. | Development of energetic pharmacophore for the designing of 1,2,3,4-tetrahydropyrimidine derivatives as selective cyclooxygenase-2 inhibitors | Deepak Lokwani, Reecha Shah, Santosh Mokale, Padma Shastry, Devanand Shinde | J. Comput. Aided Mol. Des. | 2012, 26, 267 | 2.546 |
64. | Synthesis, biological activity and docking study of imidazol-5-one as novel non-nucleoside HIV-1 reverse transcriptase inhibitors | Santosh N. Mokale, Deepak Lokwani, Devanand B. Shinde | Bioorg. Med. Chem. | 2012, 20, 3119 | 3.073 |
65. | Synthesis, Antifungal Activity, and Docking Study of Some New 1,2,4-triazole Analogs | Jaiprakash N. Sangshetti, Deepak K. Lokwani, Aniket P. Sarkate, Devanand B. Shinde | Chem. Biol. Drug. Design | 2011, 75, 800-809 | 2.548 |
66. | Synthesis and evaluation of anti-inflammatory, analgesic, ulcerogenicity and nitric oxide-releasing studies of novel ibuprofen analogs as nonulcerogenic derivatives | Aniket P. Sarkate, Deepak K. Lokwani, Ajit A. Patil, Shashikant V. Bhandari and Kailash G. Bothara | Med. Chem. Res | 2011, 20, 795-808 | 1.783 |
67. | Use of Quantitative Structure-Activity Relationship (QSAR) and ADMET prediction studies as screening methods for design of benzyl urea derivatives for anti-cancer activity | Deepak Lokwani, Shashikant Bhandari, Radha Pujari, Padma Shastri, Ganesh shelke, Vidya Pawar | J. Enz. Inhibit. Med. Chem. | 2011, 26, 319-331 | 4.673 |
68. | Design, docking study and ADME prediction of Isatin derivatives as anti-HIV agents | Vidya S. Pawar, Deepak K. Lokwani, Shashikant V. Bhandari, Kailash G. Bothara, Trupti S. Chitre, Titiksh L. Devale, Nileema S. Modhave, Jignesh K. Parikh | Med. Chem. Res. | 2011, 20, 370-380 | 1.783 |
69. | Design of potential reverse transcriptase inhibitor containing Isatin nucleus using molecular modeling studies | Vidya Pawar, Deepak Lokwani, Shashikant Bhandari, Debashis Mitra, Sudeep Sabde, Kailash Bothara, Ashwini Madgulkar | Bioorg. Med. Chem. | 2010, 18, 3198-3211 | 3.073 |
70. | Design, synthesis, and evaluation of anti-inflammatory, analgesic, ulcerogenicity, and nitric oxide releasing studies of novel indomethacin analogs as non-ulcerogenic derivatives | Shashikant V. Bhandari, Jignesh K. Parikh, Kailash G. Bothara, Trupti S. Chitre, Deepak K. Lokwani, Titiksh L. Devale, Nileema S. Modhave, Vidya S. Pawar, Santosh Panda | J. Enz. Inhibit. Med. Chem. | 2010, 25, 520-530 | 4.673 |
71. | Design of New Chemicals Entities as Selective COX–2 Inhibitors using Structure Optimization by Molecular Modeling Studies | Shashikant Bhandari, Kailash Bothara, Vidya Pawar, Deepak Lokwani, Titiksh Devale | Int. Elect. J. Mol. Design. | 2009, 8, 14–28 | 0 |
72. | Design, synthesis and pharmacological screening of novel nitric oxide donors containing 1,5-diarylpyrazolin-3-one as nontoxic NSAIDs | Shashikant V. Bhandari, Sudarshan C. Dangre, Kailash G. Bothara, Ajit A. Patil, Aniket P. Sarkate, Deepak K. Lokwani, Suraj T. Gore, Bhavana J. Deshmane, Vyankatesh T. Raparti, Chetan V. Khachane | Eur. J. Med. Chem. | 2009, 44, 2009, 4622-4636 | 5.572 |